Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Active not recruiting 4Recruiting 3Completed 3Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 1NETWORK 1INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 3Other 1

Conditions

Nasopharyngeal Carcinoma 20Squamous Cell Carcinoma of Head and Neck 7Oropharyngeal Neoplasms 7Prostatic Neoplasms 5Carcinoma 4Rectal Neoplasms 3Nasopharyngeal Neoplasms 3Mouth Neoplasms 3Laryngeal Neoplasms 3Hypopharyngeal Neoplasms 3Head and Neck Neoplasms 3Carcinoma, Squamous Cell 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Stomatitis 2Pancreatic Adenocarcinoma 2Neoplasm Metastasis 2Meningeal Carcinomatosis 2Lung Neoplasms 2Esophageal Squamous Cell Carcinoma 2Endometrial Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Uterine Neoplasms 1Urinary Bladder Neoplasms 1Tumor Virus Infections 1Thyroid Carcinoma, Anaplastic 1Stomatognathic Diseases 1Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7 1Sarcoma 1Recurrence 1

Interventions

Magnetic Resonance Spectroscopy 11Specimen Handling 9Cisplatin 8Radiation 6pembrolizumab 5Platinum 5Biopsy 51,2-diaminocyclohexaneplatinum II citrate 5Sentinel Lymph Node Biopsy 4Radiotherapy 4Drug Therapy 4cemiplimab 3X-Rays 3Ultrasonography 3Standard of Care 3Radiotherapy, Intensity-Modulated 3Cetuximab 3Carboplatin 3Taxes 2Surgical Procedures, Operative 2Practice Guidelines as Topic 2Photons 2Paclitaxel 2Interviews as Topic 2trastuzumab deruxtecan 1toripalimab 1technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 1sacituzumab govitecan 1niraparib 1merphos 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Mouth Neoplasms × Radiotherapy, Intensity-Modulated × Clear all
NCT02734537 2026-05-15

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

Eastern Cooperative Oncology Group

Phase 2 Recruiting
189 enrolled
Head & Neck

Lymphoid Interstitial Pneumonia, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms

NCT06532279 2026-05-04

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

NRG Oncology

Phase 2 Recruiting
98 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms, Stomatitis

NCT05966194 2024-11-15

KEVLARx

EpicentRx, Inc.

Phase 2 Recruiting
216 enrolled
Head & NeckOther

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Mouth Neoplasms, Stomatitis, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡